Search Results
Aug 13, 2026, 17:02 ET IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
in 2025.Operating loss of $3.8 million, compared to $0.2 million in the same period in 2025.Net loss of $6.9 million, or $0.85 per share (basic and diluted), compared to a net loss of $0.02 million, or $0.01 per share, in the same period in 2025.Financial Summary for the
More news about: IM Cannabis Corp.
Aug 13, 2026, 17:02 ET IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
in 2025.Operating loss of $3.8 million, compared to $0.2 million in the same period in 2025.Net loss of $6.9 million, or $0.85 per share (basic and diluted), compared to a net loss of $0.02 million, or $0.01 per share, in the same period in 2025.Financial Summary for the
More news about: IM Cannabis Corp.
Aug 13, 2026, 17:00 ET Mountain Province Diamonds Announces Second Quarter Financial Results for 2026
(2025: $167 per tonne) and $48 per carat recovered (2025: $209 per carat).Net loss of $120.6 million or $0.57 loss per share (2025: net loss of $37.7 million or $0.18 loss per share). Included in the determination of net loss are foreign losses of $11.3 million, the majority of which is an unrealized
More news about: Mountain Province Diamonds Inc.
Aug 13, 2026, 16:50 ET Lument Finance Trust Reports Second Quarter 2026 Results and Announces Reverse Stock Split
EarningsDistributable Earnings or Loss is a non-GAAP measure, which we define as GAAP net income (loss) attributable to holders of common stock computed in accordance with GAAP, including realized losses not otherwise included in GAAP net income (loss) and excluding (i) non-cash equity compensation, (ii) depreciation
More news about: Lument Finance Trust, Inc.
Aug 13, 2026, 16:44 ET Atrium Therapeutics Reports Second Quarter 2026 Financial Results
—Other income (expense), net328
More news about: Atrium Therapeutics
Aug 13, 2026, 16:30 ET Health In Tech Reports Second Quarter 2026 Financial Results
rate of 15% to 40%.Net loss for Q2 2026 was $2.5 million, or $(0.04) per diluted share, compared to net income of $0.6 million, or $0.01 per diluted share, in Q2 2025, and $4.1 million for the first half of 2026, or $(0.07) per diluted share, compared to net income of $1.1 million, or $0.02
More news about: Health In Tech, Inc.
Aug 13, 2026, 16:30 ET METALLA REPORTS RECORD FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2026 AND PROVIDES ASSET UPDATES
June 30, 2026, a 94% increase compared to revenue of $2.7 million for the three months ended June 30, 2025; net income of $1.2 million for the three months ended June 30, 2026, compared to a net loss of $1.7 million for the three months ended June 30, 2025; and Adjusted EBITDA of $3.9 million for the
More news about: Metalla Royalty & Streaming Ltd.
Aug 13, 2026, 16:15 ET Nektar Therapeutics Announces Second Quarter 2026 Financial Results
million in the first half of 2025.Net loss for the second quarter of 2026 was $40.6 million or $1.23 basic and diluted net loss per share as compared to net loss of $41.6 million or $2.95 basic and diluted loss per share in the second quarter of 2025. Net loss in the first half of 2026 was $85.5
More news about: Nektar Therapeutics
Aug 13, 2026, 16:15 ET Globant Reports 2026 Second Quarter Financial Results
(159,543)Net impairment losses on financial assets(2,486)
More news about: Globant
Aug 13, 2026, 16:15 ET Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
Property and equipment, net
More news about: Aethlon Medical, Inc.
Aug 13, 2026, 16:12 ET Cineverse Reports First Quarter Fiscal Year 2027 Results
and not a liquidity measure, and therefore a reconciliation between net income (loss) from operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance, or as an
More news about: Cineverse Corp.
Aug 13, 2026, 16:10 ET cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
Revenue growth accelerated year-over-year. Net sales increased 20% to $5.6 million in the third quarter of fiscal 2026 from $4.6 million in the prior-year quarter, with wholesale net sales up 61% year-over-year. For the first nine months of fiscal 2026, net sales rose 12% to $16.2 million from $14.5
More news about: cbdMD, Inc.
Aug 13, 2026, 16:10 ET VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
the comparable quarter in 2025Net cash used in operating activities was $5.2 million for the second quarter of 2026, 18% lower than the same quarter in 2025Receipts in the second quarter of 2026 included:$1.2 million in net proceeds from equity sales through our
More news about: VolitionRx Limited
Aug 13, 2026, 16:05 ET DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2026 RESULTS
incurred a net loss of $3.4 million or $0.11 per common share and generated Adjusted EBITDA of $0.6 million in the quarter ended June 30, 2026, compared to negative Adjusted EBITDA of $1.2 million in the quarter ended June 30, 2025.For the six months ended June 30, 2026, we generated net income of
More news about: Dawson Geophysical Company
Aug 13, 2026, 16:05 ET Vuzix Reports Second Quarter 2026 Results
of 3%.For the second quarter ended June 30, 2026, the net loss attributable to common shareholders was $7.7 million or $0.09 per share as compared to a loss of $7.7 million or $0.10 per share for the second quarter of 2025.Net cash used in operating activities was $6.6 million for the second
More news about: Vuzix Corporation
Aug 13, 2026, 16:04 ET Inhibrx Reports Second Quarter 2026 Financial Results
balances and a decline in short-term interest rates.Net Loss. Net loss was $36.7 million during the second quarter of 2026, or $2.34 per share, basic and diluted, as compared to a net loss of $28.7 million during the second quarter of 2025, or $1.85 per share, basic
More news about: Inhibrx Biosciences, Inc.
Aug 13, 2026, 16:01 ET HawkEye 360 Announces Second Quarter 2026 Financial Results
$9.0 million.Recorded a net loss of $15.3 million, compared to net income of $1.6 million in the prior year period.Realized Adjusted EBITDA, a non-GAAP metric, of $7.0 million, compared to $7.8 million in the prior-year period.Recognized net cash provided by operating activities
More news about: HawkEye 360 Inc.
Aug 13, 2026, 16:01 ET Co-Diagnostics Reports Second Quarter 2026 Financial Results
expensesOperating loss of $6.2 million, compared to $8.1 million in the second quarter of 2025Net loss of $6.3 million, or $1.46 per basic and diluted share, compared to a net loss of $7.7 million, or $7.00 per basic and diluted share, in the second quarter of 2025Adjusted EBITDA
More news about: Co-Diagnostics
Aug 13, 2026, 16:01 ET AudioEye Reports Record Second Quarter 2026 Results
litigation expenses.Net loss was $0.9M, or $(0.07) per share, compared to a net loss of $0.0M, or $(0.00) per share, in the same prior year period. The prior year comparable period included a $1.4M one-time gain on revaluation of contingent consideration. Removing this impact, net loss improved due primarily
More news about: AudioEye, Inc.
Aug 13, 2026, 16:00 ET Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
operations into 2027.Net LossNet loss for the second quarter of 2026 was $65.6 million, or $1.05 per share on a basic and diluted basis, as compared to a net loss of $54.3 million, or $1.03 per share on a basic and diluted basis, for the second quarter of 2025. Net loss for the second quarter
More news about: Kodiak Sciences Inc.
Aug 13, 2026, 15:48 ET Medicare Platform Secures $50 Million in Funds to Accelerate Its Mission for Senior Care
ACOs in the Medicare Shared Savings Program earned $4.1 billion in shared savings in the most recent performance year while generating $2.5 billion in net savings for Medicare. Federal health leaders have made prevention, chronic disease management, and whole-person care that addresses the root causes of
More news about: MEDICARE PLATFORM
Aug 13, 2026, 15:28 ET ICI: Money Market Fund Assets Continue to Rise in August
* Change in money market fund assets is primarily driven by flows and can be used as a proxy for net new cash flows. Note: Components may not add to the total or compute to the $ change due to rounding.Retail:3 Assets
More news about: Investment Company Institute
Aug 13, 2026, 14:54 ET PagBank affiche un revenu net récurrent de 576 millions BRL au T2 2026 et des progrès constants dans l'ensemble de son écosystème
bancaires numériques du Brésil et spécialiste des services aux entrepreneurs brésiliens, a clôturé le deuxième trimestre 2026 (T2 2026) avec un résultat net récurrent de 576 millions BRL, ce qui témoigne de la résilience de son modèle économique, même dans un contexte macroéconomique difficile.
More news about: PagBank
Aug 13, 2026, 14:41 ET Wipfli Report: Tribal Gaming Revenue Up, Profits Tightened by Rising Costs
18 states, the report found that average operating expense margins increased from 73.59% to 74.50% of revenue, contributing to a decline in average net profit margins from 26.12% to 24.50%.Despite margin compression, tribal gaming operations continued to outperform many sectors of the hospitality
More news about: Wipfli
Aug 13, 2026, 14:16 ET Sixty Compton, California Students to be Selected for Leadership and Health Advocacy Training, Powered by Health Net's $412,000 Investment
and families in underserved communities.About Health Net Founded in California more than 45 years ago, Health Net, LLC ("Health Net"), a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status
More news about: Health Net, LLC